Why is Anuh Pharma falling/rising?

As of 29-Aug, Anuh Pharma Ltd's stock is currently priced at 86.00, reflecting a decrease of 0.7, or 0.81%. The stock has been on a downward trend, having underperformed its sector by 0.84% today and experiencing a consecutive fall for the last six days, resulting in a total decline of 6.42% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -15.02%, coinciding with a significant drop in profits of 20.2%. Despite having a low debt-to-equity ratio and an attractive valuation with a return on equity of 14.2%, the company has shown poor long-term growth, which contributes to the negative sentiment surrounding its stock.
In the broader market context, Anuh Pharma's short-term performance has been notably worse than the benchmark, with a 1-week return of -4.76% compared to the Sensex's -1.84%. This underperformance is indicative of broader challenges faced by the company, particularly in light of negative quarterly results and a low dividend payout. The stock's liquidity is adequate for trading, but the falling investor participation, as evidenced by a 35.58% drop in delivery volume, suggests waning interest among investors. Overall, the combination of declining profits, poor growth prospects, and negative market sentiment has led to the stock's recent decline.